0001815776-24-000044.txt : 20240514 0001815776-24-000044.hdr.sgml : 20240514 20240514172943 ACCESSION NUMBER: 0001815776-24-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCOLLUM JAMES W CENTRAL INDEX KEY: 0001200889 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40532 FILM NUMBER: 24945953 MAIL ADDRESS: STREET 1: C/O LENZ THERAPEUTICS, INC. STREET 2: 445 MARINE VIEW AVE SUITE 320 CITY: DEL MAR STATE: CA ZIP: 92014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LENZ Therapeutics, Inc. CENTRAL INDEX KEY: 0001815776 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 844867570 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 445 MARINE VIEW AVE SUITE 320 CITY: DEL MAR STATE: CA ZIP: 92014 BUSINESS PHONE: 858-925-7000 MAIL ADDRESS: STREET 1: 445 MARINE VIEW AVE SUITE 320 CITY: DEL MAR STATE: CA ZIP: 92014 FORMER COMPANY: FORMER CONFORMED NAME: Graphite Bio, Inc. DATE OF NAME CHANGE: 20210312 FORMER COMPANY: FORMER CONFORMED NAME: Integral Medicines, Inc. DATE OF NAME CHANGE: 20200622 4 1 wk-form4_1715722170.xml FORM 4 X0508 4 2024-05-13 0 0001815776 LENZ Therapeutics, Inc. LENZ 0001200889 MCCOLLUM JAMES W C/O LENZ THERAPEUTICS, INC. 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 1 0 0 0 0 Common Stock 2024-05-13 4 P 0 31332 15.993 A 525565 I By trust Common Stock 95034 D Represents the weighted average share price of an aggregate total of 31,332 shares purchased in the price range of $15.96 to $16.00 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. /s/ Evert Schimmelpennink, as Attorney-in-Fact 2024-05-14